Assisting a biotechnology company overcome growing pains and hit key milestones
A Skarbek effect case study
A growing biotechnology company had 6 assets under development and was finding the increasing complexity of managing the critical activities to be outstripping their capability to handle the pipeline.
A growing biotechnology company had 6 assets under development and was finding the increasing complexity of managing the critical activities to be outstripping their capability to handle the pipeline.